The post Grayscale bets on ‘decentralized AI’ with first-ever Bittensor ETF filing appeared on BitcoinEthereumNews.com. While most of 2025 centered on Bitcoin [The post Grayscale bets on ‘decentralized AI’ with first-ever Bittensor ETF filing appeared on BitcoinEthereumNews.com. While most of 2025 centered on Bitcoin [

Grayscale bets on ‘decentralized AI’ with first-ever Bittensor ETF filing

While most of 2025 centered on Bitcoin [BTC], Ethereum [ETH], and Ripple [XRP] ETFs, Grayscale turned its focus to decentralized AI.

On the 30th of December, the asset manager filed an S-1 registration with the U.S. Securities and Exchange Commission to convert Grayscale Bittensor Trust into a Spot ETF.

If approved, the product would allow institutional investors to gain price-linked exposure to Bittensor’s TAO token through a U.S.-listed exchange.

The timing of the filing is as strategic as the product itself

The filing followed Bittensor’s first halving event in mid-December 2025, which reduced daily TAO emissions to 3,600 tokens. And now, Grayscale is betting on a “supply shock meets institutional demand” narrative.

With a hard cap of 21 million TAO, this reduction in emissions is designed to curb inflation and reward long-term participants.

Needless to say, the market’s reaction was also immediate.

TAO’s price reclaimed the $220 level. Moreover, it effectively wiped out intraday losses as traders priced in the potential for a fresh wave of Wall Street liquidity.

At press time, TAO climbed to $220.77, a 1.05% increase over 24 hours as per CoinMarketCap.

By taking GTAO to the NYSE Arca, Grayscale is trying to make decentralized AI a formal investment category in traditional finance.

Institutional-grade infrastructure

According to the filing, Coinbase would act as prime broker, while Coinbase Custody Trust Company and BitGo Trust Company would serve as custodians.

The trust planned to use both in-kind and cash creation and redemption mechanisms, allowing authorized participants to exchange shares directly for TAO.

However, the filing clarified that staking is not currently permitted.

The trust may only stake TAO if regulatory and tax conditions are satisfied in the future. No timeline was provided.

What’s more?

Grayscale’s push for a Bittensor ETF is not an isolated event. It is a tactical piece of a much larger, aggressive expansion.

Even as the GTAO filing grabbed headlines, Grayscale was busy refining its Avalanche [AVAX] and Sui [SUI] offerings.

Now, whether the SEC grants approval in mid-2026 remains the final variable, but for now, the institutional bridge to Decentralized AI has officially been built.


Final Thoughts

  • With emissions halved, TAO enters a structurally scarce era.
  • The next year will determine TAO’s institutional trajectory, with the ETF decision likely setting the tone for AI-token investing.
Next: Arthur Hayes sells ETH, buys DeFi – What it means for altcoin leadership

Source: https://ambcrypto.com/grayscale-bets-on-decentralized-ai-with-first-ever-bittensor-etf-filing/

Market Opportunity
Sleepless AI Logo
Sleepless AI Price(AI)
$0.03741
$0.03741$0.03741
-0.10%
USD
Sleepless AI (AI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29